- Home
- CTMX vs XFLT Comparison
CTMX vs XFLT Comparison
Compare CTMX & XFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- XFLT
- Stock Information
- Founded
- CTMX 2008
- XFLT 2017
- Country
- CTMX United States
- XFLT United States
- Employees
- CTMX N/A
- XFLT N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- XFLT Investment Managers
- Sector
- CTMX Health Care
- XFLT Finance
- Exchange
- CTMX Nasdaq
- XFLT Nasdaq
- Market Cap
- CTMX 349.6M
- XFLT 412.8M
- IPO Year
- CTMX 2015
- XFLT N/A
- Fundamental
- Price
- CTMX $2.13
- XFLT $5.58
- Analyst Decision
- CTMX Strong Buy
- XFLT
- Analyst Count
- CTMX 3
- XFLT 0
- Target Price
- CTMX $5.67
- XFLT N/A
- AVG Volume (30 Days)
- CTMX 4.1M
- XFLT 336.2K
- Earning Date
- CTMX 11-06-2025
- XFLT 01-01-0001
- Dividend Yield
- CTMX N/A
- XFLT 14.17%
- EPS Growth
- CTMX 263.20
- XFLT N/A
- EPS
- CTMX 0.49
- XFLT N/A
- Revenue
- CTMX $141,100,000.00
- XFLT N/A
- Revenue This Year
- CTMX N/A
- XFLT N/A
- Revenue Next Year
- CTMX N/A
- XFLT N/A
- P/E Ratio
- CTMX $4.66
- XFLT N/A
- Revenue Growth
- CTMX 18.01
- XFLT N/A
- 52 Week Low
- CTMX $0.40
- XFLT $6.01
- 52 Week High
- CTMX $3.10
- XFLT $7.76
- Technical
- Relative Strength Index (RSI)
- CTMX 49.61
- XFLT 56.06
- Support Level
- CTMX $2.02
- XFLT $5.40
- Resistance Level
- CTMX $2.17
- XFLT $5.62
- Average True Range (ATR)
- CTMX 0.14
- XFLT 0.06
- MACD
- CTMX 0.03
- XFLT 0.02
- Stochastic Oscillator
- CTMX 55.42
- XFLT 85.09
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About XFLT XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest
XAI Octagon Floating Rate & Alternative Income Trust is a diversified, closed-end management investment company which invests in a dynamically managed portfolio of floating-rate credit instruments and other structured credit investments within the private markets. The Trust's investment objective is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.